ArticleWorld journal of microbiology & biotechnology2025
Genome-based characterization and pathway elucidation of dibenzothiophene and 4-methyldibenzothiophene desulfurization in a thiophenic compound desulfurizing Rhodococcus sp. SB1D.
Article in World journal of microbiology & biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
In this study, we present a comprehensive characterization of a highly efficient desulfurizing bacterial isolate, SB1D. The isolate exhibited remarkable desulfurization of dibenzothiophene (DBT) and demonstrated the ability to metabolize benzothiophene (BT) and several of their alkylated derivatives. Genome-related index analyses, including 16S rRNA gene similarity (100%), Average Nucleotide Identity (ANI; 98.7%), digital DNA-DNA hybridization (dDDH; 88.7%), and phylogenomics, identified the strain as Rhodococcus qingshengii. Additionally, orthologous gene cluster analysis showed that SB1D shared the highest number of ortholog clusters (60) with R. qingshengii. The GC-MS analysis of the extracted metabolites identified 2-hydroxybiphenyl (2-HBP) and 4-methylhydroxybiphenyl (4-MHBP) as the major end-products of DBT and 4-methyldibenzothiophene (4-MDBT) desulfurization, respectively. The RAST genomic analysis revealed the presence of several organic-sulfur metabolism-related genes in the genome of SB1D. Together, these findings confirm that the isolate employs the sulfur-specific 4S pathway for the desulfurization of DBT and 4-MDBT. To our knowledge, this is the first report providing genome-based characterization and desulfurization pathway analysis of R. qingshengii SB1D, with the proven ability to desulfurize multiple thiophenic compounds found in diesel, and holds promise as a valuable biocatalyst for applications in biodesulfurization.
Indexed as
Identifiers
41205080What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.